Venous thromboembolism prophylaxis following hip and knee replacement surgery
|
|
|
|
|
|
|
Thrombosis management in special populations (obesity, thrombophilia, elderly, etc)
|
|
|
|
|
|
|
Warfarin use in 2020: who, what, why, when, how
|
|
|
|
|
|
|
Thrombosis in indigenous people
|
|
|
|
|
|
|
Peripheral vascular disease
|
|
|
|
|
|
|
Periprocedural management of anticoagulation
|
|
|
|
|
|
|
Diagnosis of DVT/PE
|
|
|
|
|
|
|
Estimating bleeding risk while on anticoagulants
|
|
|
|
|
|
|
Thrombophilia testing: pearls and pitfalls
|
|
|
|
|
|
|
Treatment of cancer associated thrombosis
|
|
|
|
|
|
|
Thrombosis management in the emergency department
|
|
|
|
|
|
|
Management of clots at unusual sites
|
|
|
|
|
|
|
Immobility and thrombosis risk
|
|
|
|
|
|
|
VTE and women's health
|
|
|
|
|
|
|
Anticoagulation and renal failure
|
|
|
|
|
|
|
Distal/below knee DVT
|
|
|
|
|
|
|
Primary prevention of cancer associated thrombosis
|
|
|
|
|
|
|
Anticoagulants and antiplatelet therapy
|
|
|
|
|
|
|
Acute and long-term management of VTE
|
|
|
|
|
|
|
Superficial venous thrombosis
|
|
|
|
|
|
|
AFib and other cardiac disease
|
|
|
|
|
|
|